Five Complainants Join Together To Win UDRP Case
In a decision issued yesterday by the National Arbitration Forum, five subsidiaries of GlaxoSmithKline PLC joined together in one UDRP case against Indian registrant Pradeep Dadha over his registration and use of 12 domain names containing the names of GlaxoSmithKline drugs with the words “Buy Generic”.
No response was filed by Dadha, and Panelist John J. Upchurch ordered the domain names transferred to the five co-complainants. The decision may be the first UDRP action involving five co-complainants.
